Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients
An Israeli study identifies associations between the use of cannabinoids and terpenes for symptoms of attention deficit hyperactivity disorder (ADHD).
An Israeli study identifies associations between the use of cannabinoids and terpenes for symptoms of attention deficit hyperactivity disorder (ADHD).
European Neuropsychopharmacology, 10 February 2020
—
Cannabis use induces a plethora of actions on the CNS via its active chemical ingredients, the so-called phytocannabinoids. These compounds have been frequently associated with the intoxicating properties of cannabis preparations. However, not all phytocannabinoids are psychot…
Physicians from the UK give their critiques of recent medical cannabis regulations, noting the narrow window of qualifying conditions that do not include chronic pain, as well as advocating for the use of lower-cost, whole-plant flowers for patients.
Clinical and experimental rheumatology, January-February 2020
—
OBJECTIVES: To assess any clinical improvement attributable to the addition of medical cannabis treatment (MCT) to the stable (>3 months) standard analgesic treatment of fibromyalgia (FM) patients, the retention rate and any changes in the concomitant analgesic treatment over …
Journal of Cannabis Research, 30 January 2020
—
Background: Hyperemesis Gravidarum (HG) responds only partially to standard antiemetic medications. Cannabis has been known to possess antiemetic effects and there are several medicinal cannabinoids used as anti -emetics for cancer chemotherapy. Its favorable use for HG has be…
Cureus, 29 January 2020
—
Background Dental plaque is a complex biofilm that gets formed on the teeth and acts as a reservoir of different microbes. It is the root cause for the occurrence of several dental problems and diseases, including cavities, bad breath, bleeding gums, tooth decay, and tooth los…
A long-term observational study found cannabis worked as an alternative to prescription opioids in over half of patients with low back pain and an be an adjunct therapy to diminish chronic opioid use for some people.
Dr. Patricia Frye summarizes a cannabis policy hearing at the House of Representatives. Dr. Frye saw strong bipartisan support for decreasing the barriers to research on cannabis medicine.
Clinical Cancer Research, 13 January 2020
—
PURPOSE: Human papillomavirus (HPV)-related head and neck squamous cell carcinoma (HNSCC) is associated with daily marijuana use and is also increasing in parallel with increased marijuana use in the United States. Our study is designed to define the interaction between cannab…
The SCC sent a poll to its membership to gauge how those within the organization were approaching the vape pen issue and EVALI. Learn more about their recommendations and considerations.
Gynecologic Oncology, 10 January 2020
—
Tetrahydrocannabinol (THC), cannabidiol (CBD) and cannabinol (CBN) affect the human endocannabinoid system. Cannabinoids reduce chemotherapy induced nausea or vomiting (CINV) and neuropathic pain. Each state has its own regulations for medical and recreational cannabis use. Ef…
Complementary Therapies in Medicine, January 2020
—
Introduction: Over-the-counter and prescribed medical cannabis products are used by patients for various conditions including psychiatric disorders, pain management, and other neurodegenerative conditions.1 Despite this growing public interest and increasing legal availability…